Thermo gives £5m backing to UK noninvasive prenatal test partner
This article was originally published in Clinica
Executive Summary
A £5m investment from its established partner Thermo Fisher will add welcome cash to Premaitha Health’s coffers and strengthen the UK firm’s credibility in the marketplace as it expands commercialization of its noninvasive prenatal test.